About
Research
Patient Care
Education & Training
Community
Sep 27, 2024
Circadian disruption, gut microbiome changes linked to colorectal cancer progression
Among “12 amazing UC discoveries of 2024” recently compiled by UC News is a UC Irvine study from September that links inconsistent sleep habits to colorectal cancer.
Aug 26, 2024
Internationally recognized cancer expert joins UCI Health as cancer center deputy director
Internationally recognized cancer expert Dr. Miguel A. Villalona-Calero has joined the UCI Health Chao Family Comprehensive Cancer Center as its deputy director and chief of the Division of Hematology-Oncology at the UC Irvine School of Medicine.
Jul 22, 2024 | UCI Health
Community open house celebrates new facilities at UCI Health ― Irvine
UCI Health hosted a vibrant open house on July 20 to celebrate the opening of the Joe C. Wen & Family Center for Advanced Care and the Chao Family Comprehensive Cancer Center at the new UCI Health – Irvine complex.
Jul 19, 2024 | UCI Health
UCI Health first in region to use new CT imaging technology
UCI Health is the first in Southern California to offer photon-counting CT scans, providing higher resolution in less time. The first scans took place on July 16 at the Chao Family Comprehensive Cancer Center in Irvine.
Jul 17, 2024 | UCI Health
UCI Health welcomes first patients to new Irvine cancer center
The UCI Health Chao Family Comprehensive Cancer Center opened its second clinical hub on July 16, marking a significant milestone in cancer care for Orange County.
Jul 15, 2024 | UCI News
UC Irvine’s electronic patient-reported outcome tool reduces cancer care disparities
A University of California, Irvine research team has developed and implemented an intervention to enhance cancer care support services for racial and ethnic minority patients undergoing chemotherapy. The electronic patient-reported outcome tool is a web-based application that allows individuals to enter their health data into a smartphone, tablet or computer.
Jun 10, 2024
‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
“Our latest research reveals that CD8+ T cells, activated by PD-1 blockade to target melanoma, also interact with T regulatory cells, which subsequently dampen the immune response against the tumor,” said corresponding author Francesco Marangoni, UC Irvine assistant professor of physiology & biophysics.
Jun 04, 2024
UCI Health cancer specialists share research at national forum
UCI Health cancer clinicians and scientists presented key findings and insights that will help advance cancer research and care at the 2024 annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s largest scientific gatherings in the field.
May 31, 2024
UCI Anti-Cancer Challenge awards $1 million for promising cancer research
The UCI Anti-Cancer Challenge has awarded $1 million raised in 2023 to fund a new round of transformative research projects at the UCI Health Chao Family Comprehensive Cancer Center and its pediatric cancer affiliate, Children’s Hospital of Orange County (CHOC).
May 28, 2024
UC Irvine study reveals circadian clock can be leveraged to enhance cancer immunotherapy
UCI researchers have found that the circadian clock can enhance the effectiveness of checkpoint inhibitor cancer therapy by optimizing immune functions and helping T cells target tumors.